Fig. 4

Differences in immune signaling pathways between high-risk and low-risk groups. Enrichment of high-risk and low-risk groups in different tumor and immune cell gene sets, (A) Tumor progression-related pathways; (B) Immune-related gene sets; (C) Immune response-related pathways; (D) Signature gene sets for the 7 steps of immune response.